Business
Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering
Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that, further to its press release of July 23, 2025, it has publicly filed an amendment to its registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to a proposed public offering of units (each, a "Unit" and collectively, the "Units") in the United States. The original registration statement was filed on July 23, 2025.
About this update from Summit Hotel Properties, Inc.
[{"type":"text","content":"HERZLIYA, Israel and CALGARY, AB, Dec. 10, 2025 /PRNewswire/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that, further to its press release of July 23, 2025, it has publicly filed an amendment to its registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to a proposed public offering of units (each, a "Unit" and collectively, the "Units") in the United States. The original registration statement was filed on July 23, 2025.","length":607,"tagName":"p"},{"type":"image","alt":"Innocan Pharma Logo (PRNewsfoto/Innocan Pharma Corporation)","displaySize":"","headline":null,"caption":"Innocan Pharma Logo (PRNewsfoto/Innocan Pharma Corporation)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":283,"url":"https://media.zenfs.com/en/cnwgroup.com/7706f970d25ba77672f989a1db7cd166"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/MQ_objxOFBZ.dAp8fl2HIw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ5OTtjZj13ZWJw/https://media.zenfs.com/en/cnwgroup.com/7706f970d25ba77672f989a1db7cd166","width":400,"height":283}},"href":"https://mma.prnewswire.com/media/2570689/Innocan_Pharma_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Each Unit will be comprised of one common share of the Company (a "Common Share") and one common share purchase warrant of the Company (a "Warrant"). Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price and term in the context of the market.","length":303,"tagName":"p"},{"type":"text","content":"Innocan has applied to list its Common Shares and Warrants on NYSE American under the symbols "INNP" and "INNPW", respectively.","length":147,"tagName":"p"},{"type":"text","content":"ThinkEquity LLC is acting as sole book-running manager for the offering.","length":72,"tagName":"p"},{"type":"text","content":"This proposed offering will be made only by means of a prospectus. Upon availability, copies of the preliminary prospectus related to the proposed offering may be obtained from ThinkEquity, 17 State Street, 41st Floor, New York, New York 10004. The final prospectus will be filed with the SEC and will be available...